CHE Chemed Corporation
Healthcare$437.33-0.46%ClosedMarket Cap: $5.81B
As of 2026-05-26
Valuation
P/E (TTM)
20.02
PEG
—
P/B
7.09
P/S
2.30
EV/EBITDA
14.64
DCF Value
$606.33
FCF Yield
6.5%
Div Yield
0.5%
Margins & Returns
Gross Margin
30.3%
Operating Margin
12.9%
Net Margin
10.2%
ROE
25.3%
ROA
16.9%
ROIC
19.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $657.5M | 30.2% | $84.6M | $66.3M | $— | $0.60 |
| Q4 null | $639.3M | 32.2% | $100.7M | $76.8M | $— | $0.60 |
| FY null | $2.53B | 30.0% | $338.2M | $265.2M | $— | $2.20 |
| Q3 null | $624.9M | 28.9% | $74.8M | $64.2M | $— | $0.60 |
| Q2 null | $618.8M | 29.8% | $68.1M | $52.5M | $— | $0.50 |
| Q1 null | $646.9M | 33.5% | $94.8M | $71.8M | $— | $0.50 |
| Q4 null | $640.0M | 36.6% | $113.9M | $90.3M | $— | $0.50 |
| FY null | $2.43B | 35.1% | $366.5M | $302.0M | $— | $1.80 |
| Q3 null | $606.2M | 34.6% | $92.2M | $75.8M | $— | $0.50 |
| Q2 null | $595.9M | 34.6% | $88.1M | $70.9M | $— | $0.40 |
| Q1 null | $589.2M | 34.6% | $72.3M | $65.0M | $— | $0.40 |
| Q4 2023 | $585.9M | 38.8% | $111.4M | $90.1M | $5.90 | $0.40 |